Date:7 September 2022
The beginning of September seems to have brought a hiatus, a pause in covid proceedings if you will, as attention is turned to the energy and promised cost of living crisis that’s about to impact citizens globally. The doomsayers in the mainstream (legacy) media are predicting the biggest recession ever seen as governments seemingly allow the rampant profiteering of the corporatocracy to continue unabated. It seems as if the world is being held to ransom as it marches inexorably to the incessant WEF drum beat, “…you will own nothing and you’ll be happy”. Well not on our watch.
Back to the covid agenda — the push to jab people with the new bivalent boosters, approved without trial data, is gathering steam as the pandemic gravy train gains further traction. Yet it’s a positive that this week, we have a smaller news offering than previous weeks.
Pushbacks & positives!
- As she starts her new role as UK Prime Minster, Liz Truss, has been sent an open letter asking her to take serious note of worrying safety signals and stop the roll out of covid jabs to UK children as the risks clearly outweigh any possible benefits
- The Naked Emperor has exposed an update to the UK’s Green Book covid jab section that the ‘one-off’ covid injection programme for children aged 5-11 years ceased at the end of August. It appears that children will not now be offered covid jabs until they are 11 or 12
- Canadian doctor, Dr William Makis, has written to the Canadian Medical Association (CMA) questioning the CMA’s stance on covid jabs following the sudden deaths of 32 young Canadian doctors in recent months, all of whom had been injected 2, 3 or 4 times
- We’re sharing a wonderful message of hope and positivity from New Zealand as the writer reflects on all they’ve learned and the good that’s come out of the past couple of years.
Restrictions and censorship
- Announcing the authorisation of Moderna’s bivalent covid jab, Canadian Prime Minister, Justin Trudeau’s message (or is that more accurately, threat?) couldn’t be clearer. Get ‘up-to-date’ with your jabs or face further tough restrictions through the coming winter.
- Michael P Senger calls into question claims that the covid pandemic began in a wet market in Wuhan, China, in a new Substack article citing multiple peer reviewed studies that show the SARS-CoV-2 virus was likely circulating globally from September 2019.
- Contrary to claims being made by governments, health authorities and the pharma companies using them, the lipid component of mRNA covid jabs create inflammation, which in turn inhibits the immune system’s ability to protect against pathogens. Mice that received two doses of LNPs, used in mRNA jabs, experienced a significant reduction in immune response following their second jab
- More than 1,000 adverse event reports have been recorded in the US VAERS system for children aged under 5 years who have received covid jabs. The majority were designated as non serious, however 19 reports were designated as serious, although the reports lacked detail on the nature of the injuries
- As people are exhorted to get their booster shots, the UK-based, Health Advisory & Recovery Team (HART) analyse a recent preprint study using data from the UK Health Security Agency (UKHSA). Looking at the supplementary data throws up major concerns as it reveals a huge disparity between hospitalisations in those who have and haven’t been jabbed. Patients who’ve received at least one covid jab were five times more likely to visit Accident & Emergency departments than those who are jab-free. There are many questions that remain unanswered in regard to what might be driving this
- A new study published in Nature discusses the risk of antibody dependent enhancement from covid jabs, although it doesn’t mention the current crop of mRNA injections
- Igor Chudov reports on what appears to be a significant drop in birth rates in England in the first few months of 2022 compared to previous years. He also notes a worrying increase in stillbirths
- Levels of prejudice against those who are jab free are exposed in a new preprint study. The study also found little evidence of prejudice from those who are jab free against those who have been injected
- China has approved a covid jab that can be inhaled as a fine mist in the hope it will improve immunity in the mucosal lining of the nose and upper airways.
- Masks don’t prevent the transmission of the SARS-CoV-2 virus according to a new Research Letter published in JAMA Network Open that followed nearly 3,000 Swiss healthcare workers over a 12 month period.
- A major new study involving over 220,000 southern Brazilians, published by our colleagues Drs Lucy Kerr, Flavio Cadegiani, Pierre Kory, Jennifer Hibberd and others, has just been published in the peer review journal, Cureus. The study found that the regular use of ivermectin as a preventative led to a 49% lower rate of infection, 100% reduction in hospitalisation rate, a 92% reduction in mortality rate, and an 86% reduction in the risk of dying from a COVID-19 infection, as compared with non-users.
- Genvax Technologies has received millions of US dollars in funding to bring self-amplifying mRNA (saRNA) jabs to the world of animal production. Its first target is the pork industry
- Far from stopping its plans to create a Pandemic Treaty, the World Health Organization (WHO) is getting ready for the next round of public hearings, which will take place on the 29th and 30th September. The WHO is asking ‘interested parties to submit a video, of up to 90 seconds in length to address the question “Based on your experience with the COVID-19 pandemic, what do you believe should be addressed at the international level to better protect against future pandemics?”. The submission period will open on Friday 9th September and close on Tuesday 13th September. The likelihood is that the videos the WHO chooses to share will be carefully screened and cherry picked to support its narrative but we would encourage you to send them your thoughts even so and share them on your media channels.
>>> Visit covidzone.org for our complete curated covid content during the coronavirus crisis